Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 vs Triamcinolone in Oral Lichen Planus
NCT04091698Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Oct 2019
- Primary completion
- Oct 2021
01
Overview
Phase 1, randomised, open-label trial of coenzyme q10 in oral lichen planus (OLP) (2 arms), sponsored by Cairo University. Primary endpoints: Pain at 3 months and Clinical size of lesion at 3 months. Status: unknown.
02
Drugs
coenzyme q10
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT04091698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04091698.